Koninklijke Philips N.V.

PHG Healthcare Medical Devices

Koninklijke Philips N.V.’s revenue for fiscal 2025 (year ended December 2025) was $20.2 billion, up 3.47% from fiscal 2024. In the quarter to June 2026, revenue grew 2.94%, EPS grew 56.7%, free cash flow grew 49.7% and total debt fell 9.93%, each against the same quarter a year earlier.

25.74 0.25 +0.98%
Market cap
$24.9B
P/E
18.8×
Fwd P/E
11.2×
Dividend yield
3.94%
F-score
7/9
Altman Z
1.98
Beneish M
−2.68
Dividend safety
55/100
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Piotroski F-Score
7 — — —

+8 more TTM periods

ROE
10.20% 8.63% 8.02% 5.98%
ROA
4.21% 3.67% 3.25% 2.44%
ROIC
6.69% 5.91% 5.91% 4.64%
Return on Tangible Assets
27.07% 20.90% 19.29% 14.68%
Average Days of Receivables
74.19 69.14 73.47 74.25
Free Cash Flow per Share
1.94 1.85 0.61 (1.30)
Free Cash Flow
1,849.65 1,763.60 580.41 (1,234.96)
Capital Expenditures
(751.93) (765.35) (745.59) (890.67)
Other line items
Cash ROIC
8.10% 7.18% 2.47% (5.33%)
Accounts Receivable Turnover
5.17 5.42 4.86 4.71
Accounts Payable Turnover
3.70 5.26 5.30 5.48
Inventory Turnover
3.00 3.13 3.10 2.52
Average Days of Payables
79.35 75.92 71.95 70.19
Days of Inventory on Hand
122.68 118.66 107.16 133.57
Tax Rate
(0.25) (0.24) (0.24) (0.29)
Research and Development Expense of Revenue
9.77% 9.31% 9.53% 9.95%
Selling, General and Administrative Expense of Revenue
27.66% 27.87% 27.87% 28.54%
Share Based Compensation of Revenue
0.80% 0.71% 0.79% 0.89%
Interest Coverage
4.70 4.30 4.12 3.59
Operating CF/Net income
2.03 2.28 1.31 (0.45)
Depreciation/Fixed assets
0.56 0.51 0.51 0.65
Capex/Depreciation
(0.53) (0.59) (0.59) (0.53)
Revenue per Share
21.53 21.47 21.28 20.07
Operating CF per Share
2.72 2.66 1.40 (0.36)
Capex per Share
(0.79) (0.80) (0.79) (0.94)
Capex to Sales
0.04 0.04 0.04 0.05

Fold the line items

Columns are period end dates